Gallos George, Ruyle Thomas D, Emala Charles W, Lee H Thomas
Department of Anesthesiology, Columbia University, New York, NY 10032-3784, USA.
Am J Physiol Renal Physiol. 2005 Aug;289(2):F369-76. doi: 10.1152/ajprenal.00470.2004. Epub 2005 Mar 22.
Sepsis is a leading cause of multiorgan dysfunction and death in hospitalized patients. Dysregulated inflammatory processes and apoptosis contribute to the pathogenesis of sepsis-induced organ dysfunction and death. A(1) adenosine receptor (A(1)AR) activation reduces inflammation and apoptosis after ischemia-reperfusion injury. Therefore, we questioned whether A(1)AR-mediated reduction of inflammation and apoptosis could improve mortality and organ dysfunction in a murine model of sepsis. A(1)AR knockout mice (A(1) knockout) and their wild-type (A(1) wild-type) littermate controls were subjected to cecal ligation and double puncture (CLP) with a 20-gauge needle. A(1) knockout mice or A(1) wild-type mice treated with 1,3-dipropyl-8-cyclopentylxanthine (a selective A(1)AR antagonist) had a significantly higher mortality rate compared with A(1) wild-type mice following CLP. Mice lacking endogenous A(1)ARs demonstrated significant elevations in plasma creatinine, alanine aminotransferase, aspartate aminotransferase, keratinocyte-derived chemokine, and tumor necrosis factor-alpha 24 h after induction of sepsis compared with wild-type mice. The renal corticomedullary junction from A(1) knockout mice also exhibited increased myeloperoxidase activity, intercellular adhesion molecule-1 protein, and mRNA encoding proinflammatory cytokines compared with renal samples from A(1) wild-type littermate controls. No difference in renal tubular apoptosis was detected between A(1) knockout and A(1) wild-type mice. We conclude that endogenous A(1)AR activation confers a protective effect in mice from septic peritonitis primarily by attenuating the hyperacute inflammatory response in sepsis.
脓毒症是住院患者多器官功能障碍和死亡的主要原因。炎症过程失调和细胞凋亡导致脓毒症诱导的器官功能障碍和死亡的发病机制。A(1) 腺苷受体(A(1)AR)激活可减轻缺血再灌注损伤后的炎症和细胞凋亡。因此,我们质疑 A(1)AR 介导的炎症和细胞凋亡减少是否能改善脓毒症小鼠模型的死亡率和器官功能障碍。将 A(1)AR 基因敲除小鼠(A(1) 敲除)及其野生型(A(1) 野生型)同窝对照小鼠用 20 号针头进行盲肠结扎和双穿刺(CLP)。与 CLP 后的 A(1) 野生型小鼠相比,用 1,3 - 二丙基 - 8 - 环戊基黄嘌呤(一种选择性 A(1)AR 拮抗剂)处理的 A(1) 敲除小鼠或 A(1) 野生型小鼠的死亡率显著更高。与野生型小鼠相比,缺乏内源性 A(1)AR 的小鼠在脓毒症诱导后 24 小时血浆肌酐、丙氨酸转氨酶、天冬氨酸转氨酶、角质形成细胞衍生趋化因子和肿瘤坏死因子 -α 显著升高。与 A(1) 野生型同窝对照小鼠的肾脏样本相比,A(1) 敲除小鼠的肾皮质髓质交界处髓过氧化物酶活性、细胞间黏附分子 -1 蛋白和编码促炎细胞因子的 mRNA 也增加。在 A(1) 敲除小鼠和 A(1) 野生型小鼠之间未检测到肾小管凋亡的差异。我们得出结论,内源性 A(1)AR 激活主要通过减轻脓毒症中的超急性炎症反应,对脓毒症性腹膜炎小鼠起到保护作用。